Glaukos Announces First Quarter 2023 Financial Results

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced... | May 3, 2023

Related Keywords

Thomas Burns ,International Glaucoma ,Ivantis Inc ,Corneal Health ,Glaukos Corporation ,Avedro Inc ,Exchange Commission ,Investor Relations ,Quarterly Summary ,Micro Invasive Glaucoma Surgery ,Annual Report ,Quarterly Report ,Investor Section ,Regarding Use ,Generally Accepted Accounting Principles ,Glaukos Corporation Stock Exchange ,News ,Information ,Press Release ,Glaukos ,Corporation ,N ,Ophthalmic ,Medical ,Technology ,End ,Harmaceutical ,Company ,Ocused ,Novel ,Therapies ,Or ,The ,Treatment ,F ,Corneal ,Disorders ,Retinal ,Oday Gkos Us3773221029 ,